Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LSS | P48449 | 1/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL132013 | 0.89 | KCNH2 (0.49) | KCNH2HRH3LTA4HSMN1; SMN2LSS | |
| SCHEMBL9475161 | 0.81 | KCNH2 (0.44) | KCNH2HRH3LTA4HSMN1; SMN2LSS | |
| SCHEMBL10520360 | 0.81 | KCNH2 (0.48) | KCNH2HRH3LTA4HSMN1; SMN2LSS | |
| SCHEMBL20410837 | 0.81 | KCNH2 (0.44) | KCNH2HRH3LTA4HSMN1; SMN2LSS | |
| SCHEMBL1856955 | 0.79 | NPC1 (0.43) | ALDH1A1HPGDKCNH2HRH3LTA4H | |
| SCHEMBL20410952 | 0.79 | KCNH2 (0.43) | KCNH2HRH3LTA4HSMN1; SMN2LSS | |
| SCHEMBL1817200 | 0.79 | LSS (0.51) | ALDH1A1KCNH2HRH3LTA4HLSS | |
| SCHEMBL961792 | 0.79 | KCNN4 (0.44) | ALDH1A1HPGDKCNH2HRH3LTA4H | |
| SCHEMBL17677999 | 0.79 | KCNH2 (0.43) | KCNH2HRH3LTA4HSMN1; SMN2LSS | |
| SCHEMBL1814199 | 0.79 | KCNH2 (0.43) | ALDH1A1HPGDKCNH2HRH3LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115108987-B | N-substituted indenoisoquinolinone derivative and preparation method thereof | 华侨大学 | 2023-05-26 | — | — | CN | claimed |
| CN-115108987-A | N-substituted indenoisoquinolinone derivative and preparation method thereof | 华侨大学 | 2022-09-27 | — | — | CN | claimed |
| CN-115108987-B | N-substituted indenoisoquinolinone derivative and preparation method thereof | 华侨大学 | 2023-05-26 | — | — | CN | disclosed |
| CN-114736358-B | Preparation method and recovery method of recyclable PETG material | 河南源宏高分子新材料有限公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-115108987-A | N-substituted indenoisoquinolinone derivative and preparation method thereof | 华侨大学 | 2022-09-27 | — | — | CN | disclosed |
| CN-114736358-A | Preparation method and recovery method of recyclable PETG material | 河南源宏高分子新材料有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-113999131-B | Method for preparing amide derivative by amination of alkyl C-H bond under catalysis of nickel promoted by visible light | 苏州大学 | 2022-06-28 | — | — | CN | disclosed |
| US-11342511-B2 | Azoline ring-containing compound, electron transport/injection layer material containing the same, and organic electroluminescent element using the same | SK MATERIALS JNC CO., LTD. (KR) | 2022-05-24 | — | — | US | disclosed |
| US-11342511-B2 | Azoline ring-containing compound, electron transport/injection layer material containing the same, and organic electroluminescent element using the same | SK MATERIALS JNC CO., LTD. (KR) | 2022-05-24 | — | — | US | disclosed |
| CN-107531641-B | Material for transporting electrons, organic electroluminescent element, and display device or lighting device | 爱思开新材料捷恩智株式会社 | 2022-03-15 | — | — | CN | disclosed |
| CN-113999131-A | Method for preparing amide derivative by amination of alkyl C-H bond under catalysis of nickel promoted by visible light | 苏州大学 | 2022-02-01 | — | — | CN | disclosed |
| US-20050003408-A1 | Libraries of oligomers labeled with different tags | ISIS INNOVATION LIMITED (GB) | 2005-01-06 | — | — | US | disclosed |
| US-6780981-B1 | MAKING A SET OF LABELLED COMPOUNDS BY THE USE OF PARTICULATE SUPPORT, COMPRISES DIVIDING THE SUPPORT INTO LOTS, PERFORMING A DIFFERENT CHEMICAL REACTION ON EACH LOT OF THE SUPPORT | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2004-08-24 | — | — | US | disclosed |
| EP-1428810-A2 | Libraries of oligomers labelled with different tags | Oxford Gene Technology IP Limited (GB) | 2004-06-16 | — | — | EP | disclosed |
| EP-1068216-B1 | LIBRARIES OF OLIGOMERS LABELLED WITH DIFFERENT TAGS | ISIS INNOVATION (GB) | 2003-12-10 | — | — | EP | disclosed |
| EP-1068216-A2 | LIBRARIES OF OLIGOMERS LABELLED WITH DIFFERENT TAGS | ISIS INNOVATION LIMITED (GB) | 2001-01-17 | — | — | EP | disclosed |
| WO-1999060007-A2 | LIBRARIES OF OLIGOMERS LABELLED WITH DIFFERENT TAGS | ISIS INNOVATION LIMITED (GB) | 1999-11-25 | — | — | WO | disclosed |
| US-5559141-A | TREATMENT OF BREAST CANCER AND BENIGN PROSTATE HYPERPLASIA | ORION-YHTYMA OY (FI) | 1996-09-24 | — | — | US | disclosed |
| EP-0589975-A1 | NEW SELECTIVE AROMATASE INHIBITING 4(5)-IMIDAZOLES | ORION-YHTYMÀ OY (FI) | 1994-04-06 | — | — | EP | disclosed |
| WO-1992022537-A1 | NEW SELECTIVE AROMATASE INHIBITING 4(5)-IMIDAZOLES | Orion-Yhtymä Oy (FI) | 1992-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11342511-B2 | Azoline ring-containing compound, electron transport/injection layer material containing the same, and organic electroluminescent element using the same | SLC7A5, EML4, ARNT | ALDH1A1 1266/4885HPGD 4501/4885KCNH2 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.